TFG Asset Management GP Ltd - Q4 2016 holdings

$504 Million is the total value of TFG Asset Management GP Ltd's 38 reported holdings in Q4 2016. The portfolio turnover from Q3 2016 to Q4 2016 was 35.3% .

 Value Shares↓ Weighting
BuyJAZZ US HLDGS INCnote 8.000%12/3$59,145,000
+40.6%
29,779,000
+14.6%
11.75%
+47.5%
MON SellMONSANTO CO NEW$57,866,000
-12.9%
550,000
-15.4%
11.49%
-8.6%
BuyGLOBALSTAR INCnote 8.000% 4/0$40,005,000
+30.7%
15,807,929
+2.7%
7.94%
+37.1%
BuyINTEL CORPsdcv 12/1$39,811,000
+218.0%
29,400,000
+226.7%
7.91%
+233.6%
ARRS SellARRIS INTL INC$39,169,000
-13.6%
1,300,000
-18.8%
7.78%
-9.3%
GMWSB SellGENERAL MTRS CO*w exp 07/10/201$32,920,000
+20.0%
1,918,422
-2.4%
6.54%
+25.9%
 LEXICON PHARMACEUTICALS INCnote 5.250%12/0$31,512,000
-21.0%
17,500,0000.0%6.26%
-17.1%
NewSUCAMPO PHARMACEUTICALS INCdbcv 3.250%12/1$21,041,00019,750,000
+100.0%
4.18%
BuyYAHOO INCnote 12/0$17,328,000
+68.0%
17,500,000
+74.1%
3.44%
+76.3%
BuySTARWOOD PPTY TR INCnote 3.750%10/1$15,022,000
+19.9%
14,500,000
+20.8%
2.98%
+25.8%
SHPG BuySHIRE PLCsponsored adr$14,863,000
+31.4%
87,234
+49.5%
2.95%
+37.8%
 B2GOLD CORPnote 3.250%10/0$14,718,000
-2.7%
14,500,0000.0%2.92%
+2.0%
BuyACCURAY INCnote 3.500% 2/0$14,625,000
-16.3%
13,750,000
+3.8%
2.90%
-12.2%
BuyALLEGHENY TECHNOLOGIES INCnote 4.750% 7/0$13,674,000
+12.7%
10,000,000
+17.6%
2.72%
+18.2%
 LIGAND PHARMACEUTICALS INCnote 0.750% 8/1$11,729,000
-1.1%
8,100,0000.0%2.33%
+3.8%
BuyLGI HOMES INCnote 4.250%11/1$10,819,000
+46.4%
7,500,000
+78.6%
2.15%
+53.6%
SPY  SPDR S&P 500 ETF TRput$10,815,0000.0%50,0000.0%2.15%
+4.9%
 MERCADOLIBRE INCnote 2.250% 7/0$10,466,000
-11.2%
7,500,0000.0%2.08%
-6.8%
BuyINOTEK PHARMACEUTICALS CORPnote 5.750% 8/0$10,181,000
+3.5%
9,700,000
+34.7%
2.02%
+8.6%
 MEDICINES COdbcv 1.375% 6/0$9,652,000
-9.9%
7,210,0000.0%1.92%
-5.5%
NewCARRIAGE SVCS INCnote 2.750% 3/1$5,089,0003,723,000
+100.0%
1.01%
SellTRULIA INCnote 2.750%12/1$4,123,000
-90.8%
2,500,000
-91.4%
0.82%
-90.3%
 ACCURAY INCdebt 3.500% 2/0$4,086,000
-17.0%
3,750,0000.0%0.81%
-13.0%
NewSUNPOWER CORPdbcv 4.000% 1/1$3,640,0005,000,000
+100.0%
0.72%
NewTHERAVANCE BIOPHARMA INCnote 3.250%11/0$2,885,0002,500,000
+100.0%
0.57%
SALT SellSCORPIO BULKERS INC$2,576,000
-56.7%
510,186
-70.3%
0.51%
-54.6%
GCVRZ NewSANOFIright 12/31/2020$1,015,0002,670,316
+100.0%
0.20%
WMGIZ BuyWRIGHT MED GROUP N Vright 03/01/2019$976,000
+4.6%
739,304
+3.8%
0.19%
+9.6%
GG SellGOLDCORP INC NEW$884,000
-73.9%
65,000
-68.3%
0.18%
-72.5%
SellCOBALT INTL ENERGY INCnote 2.625%12/0$847,000
-59.6%
2,000,000
-50.0%
0.17%
-57.6%
NVRO  NEVRO CORP$828,000
-30.4%
11,4000.0%0.16%
-27.1%
AKG SellASANKO GOLD INC$449,000
-85.1%
146,500
-79.7%
0.09%
-84.4%
HLSWS BuyHEALTHSOUTH CORP*w exp 01/17/201$419,000
-41.6%
625,875
+109.4%
0.08%
-39.0%
AAU NewALMADEN MINERALS LTD$338,000346,400
+100.0%
0.07%
GOGL ExitGOLDEN OCEAN GROUP LTD$0-21,972
-100.0%
-0.02%
ExitALMADEN MINERALS LTD$0-335,600
-100.0%
-0.09%
FCX ExitFREEPORT-MCMORAN INCput$0-500,000
-100.0%
-1.03%
ExitMERRIMACK PHARMACEUTICALS INnote 4.500% 7/1$0-4,500,000
-100.0%
-1.06%
POT ExitPOTASH CORP SASK INC$0-1,273,610
-100.0%
-3.93%
ExitENDOLOGIX INCnote 3.250%11/0$0-17,450,000
-100.0%
-4.41%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2017-02-13
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
LEXICON PHARMACEUTICALS INC24Q3 202195.6%
ALLEGHENY TECHNOLOGIES INC22Q4 20216.1%
AUTOLUS THERAPEUTICS PLC22Q3 20235.1%
TAKEDA PHARMACEUTICAL CO LTD19Q3 20235.4%
NICE SYS INC18Q3 20235.0%
TRULIA INC18Q3 20208.9%
WORLD WRESTLING ENTMT INC17Q1 202311.1%
RENEWABLE ENERGY GROUP INC16Q1 202111.2%
PRECIGEN INC16Q2 20221.5%
HOSTESS BRANDS INC15Q1 20210.3%

View TFG Asset Management GP Ltd's complete holdings history.

Latest significant ownerships (13-D/G)
TFG Asset Management GP Ltd Q4 2016 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
CorEnergy Infrastructure Trust, Inc.February 03, 2020260,0001.9%
IMMUNOGEN INCFebruary 14, 2018500.0%
SYNERGY PHARMACEUTICALS, INC.Sold outFebruary 13, 201700.0%
INOTEK PHARMACEUTICALS CORPSold outFebruary 12, 201600.0%
NextWave Wireless Inc.Sold outJanuary 30, 20130-
TRUMP ENTERTAINMENT RESORTS, INC.June 24, 20112,525,43223.6%

View TFG Asset Management GP Ltd's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14
13F-HR2021-11-15

View TFG Asset Management GP Ltd's complete filings history.

Compare quarters

Export TFG Asset Management GP Ltd's holdings